Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock.
Gennaro Giustino, Brian P O'Neill, Dee Dee Wang...
https://pubmed.ncbi.nlm.nih.gov/38629421/Actively Recruiting
Led by Atlantic Health System · Updated on 2025-12-30
30
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are evaluating the use of pre-emptive left atrial veno-arterial extracorporeal membrane oxygenation LAVA-ECMO in adults undergoing complex and high-risk transcatheter aortic valve replacement TAVR. This study focuses on patients with severe aortic stenosis who are either hemodynamically unstable or at risk of instability due to anatomical complexity. The trial aims to determine if LAVA-ECMO can reduce the risk of in-hospital death, cardiac arrest during the procedure, or emergency cardiac surgery, as well as assess safety outcomes related to major vascular, bleeding, or cardiac complications.
CONDITIONS
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
G
Gennaro Giustino, MD
P
Pedro Villablanca, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Atlantic Health System
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - During the TAVR procedure and hospitalization (up to 30 days)
Participants undergo the pre-emptive placement of the Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO) device prior to or at the start of the high-risk transcatheter aortic valve replacement (TAVR) procedure to provide mechanical circulatory support and left ventricular unloading.
1 procedure visit and hospital stay (up to 30 days)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Gennaro Giustino, Brian P O'Neill, Dee Dee Wang...
https://pubmed.ncbi.nlm.nih.gov/38629421/Michael Chiang, Pedro E Gonzalez, Brian P O'Neill...
https://pubmed.ncbi.nlm.nih.gov/35257102/Alejandro Lemor, Mir B Basir, Brian P O'Neill...
https://pubmed.ncbi.nlm.nih.gov/37288119/Aditya Sabharwal, Athanasios Tsiouris, Mark S Slaughter...
https://pubmed.ncbi.nlm.nih.gov/37913501/Jean-Louis Vincent, Daniel De Backer
https://pubmed.ncbi.nlm.nih.gov/24171518/Pedro A Villablanca, Waleed Al-Darzi, Andrew Boshara...
https://pubmed.ncbi.nlm.nih.gov/36265949/Michael Chiang, Pedro E Gonzalez, Mir Babar Basir...
https://pubmed.ncbi.nlm.nih.gov/35981853/Raunak M Nair, Sanchit Chawla, Feras Alkhalaileh...
https://pubmed.ncbi.nlm.nih.gov/39429239/VARC-3 WRITING COMMITTEE:, Philippe Généreux, Nicolo Piazza...
https://pubmed.ncbi.nlm.nih.gov/33888385/Daniel Burkhoff, Gabriel Sayer, Darshan Doshi...
https://pubmed.ncbi.nlm.nih.gov/26670067/Atlantic Health System
Lead Sponsor